Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS).

Berman, Ellin

Resistance to imatinib in patients with chronic myelogenous leukemia and the splice variant BCR-ABL1(35INS). [electronic resource] - Leukemia research 10 2016 - 108-12 p. digital

Publication Type: Journal Article

1873-5835

10.1016/j.leukres.2016.08.006 doi


Adolescent
Adult
Aged
Female
Humans
Imatinib Mesylate--pharmacology
Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy
Male
Middle Aged
Mutagenesis, Insertional
Protein Kinase Inhibitors--therapeutic use
RNA Splicing--genetics
Retrospective Studies
Sequence Analysis, DNA
Treatment Failure
Young Adult